Results 251 to 259 of about 2,728,064 (259)

Erenumab in Chronic Migraine: An Australian Experience

Headache, 2020
To determine the effectiveness and safety of erenumab in patients with chronic migraine in the real‐world setting of 3 headache centers in Australia.
Shuli Cheng, B. Jenkins, Nicole Limberg, E. Hutton   +3 more
semanticscholar   +1 more source

How does the brain change in chronic migraine? Developing disease biomarkers

Cephalalgia, 2020
Background Validated chronic migraine biomarkers could improve diagnostic, prognostic, and predictive abilities for clinicians and researchers, as well as increase knowledge on migraine pathophysiology. Objective The objective of this narrative review is
P. Pozo-Rosich, G. Coppola, J. Pascual, T. Schwedt   +3 more
semanticscholar   +1 more source

Hypersensitivity to calcitonin gene-related peptide in chronic migraine

Cephalalgia, 2020
Objective To investigate if calcitonin gene-related peptide infusion induces migraine-like attacks in chronic migraine patients. Methods Fifty-eight patients with chronic migraine, either with or without headache on the experimental day, were assessed ...
Afrim Iljazi, Håkan Ashina, Z. Zhuang, Cristina Lopez Lopez, J. Snellman, M. Ashina, H. Schytz   +6 more
semanticscholar   +1 more source

Interictal amylin levels in chronic migraine patients: A case-control study

Cephalalgia, 2020
Background Recently, amylin and its receptors were found in different structures involved in migraine pathophysiology. Here, we evaluate interictal concentrations of amylin and calcitonin gene-related peptide in peripheral blood as biomarkers for chronic
P. Irimia, Iván Martínez-Valbuena, Ane Mínguez-Olaondo, C. Domínguez‐Vivero, J. Sánchez-Arias, E. Martı́nez-Vila, M. Luquin, R. Leira   +7 more
semanticscholar   +1 more source

Eptinezumab for prevention of chronic migraine: A randomized phase 2b clinical trial

Cephalalgia, 2019
Background Calcitonin gene-related peptide plays an important role in migraine pathophysiology. We evaluated eptinezumab, an intravenous (IV) anti-calcitonin gene-related peptide monoclonal antibody, for the prevention of chronic migraine.
D. Dodick, R. Lipton, S. Silberstein, P. Goadsby, D. Biondi, J. Hirman, R. Cady, Jeffrey T. L. Smith   +7 more
semanticscholar   +1 more source

Effectiveness of ketogenic diet in treatment of patients with refractory chronic migraine

Neurological Sciences, 2021
D. Bongiovanni, C. Benedetto, S. Corvisieri, C. del Favero, F. Orlandi, G. Allais, Silvia Sinigaglia, M. Fadda   +7 more
semanticscholar   +1 more source

Real-life assessment of erenumab in refractory chronic migraine with medication overuse headache

Neurological Sciences, 2021
Umberto Pensato, C. Baraldi, V. Favoni, M. Cainazzo, P. Torelli, Pietro Querzani, A. Pascazio, Davide Mascarella, Eleonora Matteo, Simone Quintana, G. Asioli, P. Cortelli, G. Pierangeli, S. Guerzoni, S. Cevoli   +14 more
semanticscholar   +1 more source

Exercise in Treatment of Migraine Including Chronic Migraine

Current Pain and Headache Reports, 2021
Tae-Jin Song, M. Chu
semanticscholar   +1 more source

Searching for Predictors of Migraine Chronification: a Pilot Study of 1911A>G Polymorphism of TRPV1 Gene in Episodic Versus Chronic Migraine

Journal of Molecular Neuroscience, 2020
A. Yakubova, Y. Davidyuk, J. Tohka, O. Khayrutdinova, I. Kudryavtsev, Dilyara Nurkhametova, A. Kamshilin, R. Giniatullin, A. Rizvanov   +8 more
semanticscholar   +1 more source